Compare CDIO & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDIO | VS |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 6.1M |
| IPO Year | N/A | N/A |
| Metric | CDIO | VS |
|---|---|---|
| Price | $1.51 | $1.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 14.2K |
| Earning Date | 03-19-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,782.00 | ★ $2,179,348.00 |
| Revenue This Year | $1,434.82 | $3,459.21 |
| Revenue Next Year | $4,661.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2281.70 |
| 52 Week Low | $1.53 | $1.15 |
| 52 Week High | $20.55 | $2.83 |
| Indicator | CDIO | VS |
|---|---|---|
| Relative Strength Index (RSI) | 27.62 | 37.91 |
| Support Level | $1.65 | $1.22 |
| Resistance Level | $1.87 | $1.27 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 3.54 | 21.43 |
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.